Gutensohn et al., 2013 - Google Patents
Validation of cord blood split products prepared by an automated methodGutensohn et al., 2013
- Document ID
- 13000459263769515381
- Author
- Gutensohn K
- Odendahl M
- Kersten J
- Tonn T
- Publication year
- Publication venue
- Transfusion Medicine
External Links
Snippet
Objectives In this study, we studied whether the contents of the two compartments of automatically processed cord blood (CB) units are comparable with respect to cell counts and viability and therefore suitable for clinical therapy. Background CB‐derived stem cells …
- 210000004700 Fetal Blood 0 title abstract description 52
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rubinstein | Cord blood banking for clinical transplantation | |
Chen et al. | Comparison of the effects of different cryoprotectants on stem cells from umbilical cord blood | |
Armitage et al. | Cord blood banking: volume reduction of cord blood units using a semi-automated closed system | |
Briard et al. | Small-molecule ice recrystallization inhibitors improve the post-thaw function of hematopoietic stem and progenitor cells | |
Solves et al. | Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative study | |
Frisch et al. | Hematopoietic stem cell cultures and assays | |
AU2012217778B2 (en) | Stem cells packaging and shipping | |
Meyer et al. | Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood | |
Solves et al. | Red blood cell depletion with a semiautomated system or hydroxyethyl starch sedimentation for routine cord blood banking: a comparative study | |
Lanza et al. | Manipulation, and cryopreservation of autologous peripheral blood stem cell products in Italy: A survey by GITMO, SIDEM and GIIMA societies | |
Kao et al. | Validation of short‐term handling and storage conditions for marrow and peripheral blood stem cell products | |
Watt et al. | Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use | |
Appleman et al. | Cryopreservation of canine platelets | |
Lawce et al. | Peripheral blood cytogenetic methods | |
Querol et al. | Direct immunomagnetic method for CD34+ cell selection from cryopreserved cord blood grafts for ex vivo expansion protocols | |
Gniadek et al. | Optimal storage conditions for apheresis research (OSCAR): a biomedical excellence for safer transfusion (BEST) collaborative study | |
Jansen et al. | Transportation of peripheral blood progenitor cell products: effects of time, temperature and cell concentration | |
Scott et al. | Use of liquid patient ascites fluids as a preclinical model for oncolytic virus activity | |
Martin‐Henao et al. | Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation | |
Gutensohn et al. | Validation of cord blood split products prepared by an automated method | |
Eichler et al. | Engraftment capacity of umbilical cord blood cells processed by either whole blood preparation or filtration | |
Heuer et al. | Flow cytometric characterization of hematopoietic stem and progenitor cell subpopulations in autologous peripheral blood stem cell preparations after cryopreservation | |
Frisch | Hematopoietic stem cell cultures and assays | |
Tran et al. | Optimized processing of growth factor mobilized peripheral blood CD34+ products by counterflow centrifugal elutriation | |
Jansen et al. | Transportation of peripheral blood progenitor cell products: effect of ambient temperature |